We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+9.4%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$27.8B
AUM Growth
+$2.54B
Cap. Flow
+$477M
Cap. Flow %
1.71%
Top 10 Hldgs %
17.19%
Holding
2,397
New
92
Increased
1,264
Reduced
960
Closed
73

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$37.3M
2
JNJ icon
Johnson & Johnson
JNJ
+$35.5M
3
VZ icon
Verizon
VZ
+$26.4M
4
TFC icon
Truist Financial
TFC
+$26.1M
5
CTXS
Citrix Systems Inc
CTXS
+$18.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$53.1M
2
STI
SunTrust Banks, Inc.
STI
+$25.3M
3
CHL
China Mobile Limited
CHL
+$16.9M
4
CUK
Carnival PLC
CUK
+$15M
5
WBK
Westpac Banking Corporation
WBK
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 20.1%
2 Financials 16.78%
3 Healthcare 13.34%
4 Consumer Discretionary 9.48%
5 Communication Services 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACH
2276
Accendra Health
ACH
$254M
$89K ﹤0.01%
17,185
-17,664
-51% -$113K
VSLR
2277
DELISTED
VIVINT SOLAR, INC.
VSLR
$89K ﹤0.01%
12,295
-5,886
-32% -$41.5K
PTNR
2278
DELISTED
Partner Communications
PTNR
$84K ﹤0.01%
19,177
-259
-1% -$1.14K
WOW
2279
DELISTED
WideOpenWest
WOW
$82K ﹤0.01%
11,075
+424
+4% +$2.69K
GRPN icon
2280
Groupon
GRPN
$1.03B
$81K ﹤0.01%
1,702
+316
+23% +$17.5K
GORO icon
2281
Goldgroup Mining Inc.
GORO
$155M
$79K ﹤0.01%
+14,176
New +$61.9K
TELL
2282
DELISTED
Tellurian Inc.
TELL
$78K ﹤0.01%
10,693
-942
-8% -$7.17K
RIGL icon
2283
Rigel Pharmaceuticals
RIGL
$723M
$77K ﹤0.01%
3,618
+427
+13% +$8.79K
ACHN
2284
DELISTED
Achillion Pharmaceuticals
ACHN
$76K ﹤0.01%
12,635
+1,363
+12% +$7.89K
KDMN
2285
DELISTED
Kadmon Holdings, Inc.
KDMN
$75K ﹤0.01%
16,525
-1,414
-8% -$5.17K
CBAY
2286
DELISTED
Cymabay Therapeutics
CBAY
$73K ﹤0.01%
36,788
+19,927
+118% +$74.8K
IOVA icon
2287
Iovance Biotherapeutics
IOVA
$2.04B
$72K ﹤0.01%
+2,616
New +$59.5K
AKBA icon
2288
Akebia Therapeutics
AKBA
$338M
$66K ﹤0.01%
10,368
-4,015
-28% -$19.1K
HOME
2289
DELISTED
At Home Group Inc.
HOME
$64K ﹤0.01%
11,676
-2,647
-18% -$21.5K
BCRX icon
2290
BioCryst Pharmaceuticals
BCRX
$2.42B
$62K ﹤0.01%
17,859
-17,687
-50% -$44.5K
ABEO icon
2291
Abeona Therapeutics
ABEO
$355M
$58K ﹤0.01%
705
+172
+32% +$12.1K
PGEN icon
2292
Precigen
PGEN
$1.94B
$57K ﹤0.01%
10,411
-1,314
-11% -$7.4K
SPPI
2293
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$57K ﹤0.01%
15,672
-12,236
-44% -$98.9K
CDR
2294
DELISTED
Cedar Realty Trust, Inc
CDR
$57K ﹤0.01%
2,937
+611
+26% +$11.9K
BTE icon
2295
Baytex Energy
BTE
$2.96B
$56K ﹤0.01%
38,936
-26,200
-40% -$32.4K
HWKN icon
2296
Hawkins
HWKN
$2.9B
$53K ﹤0.01%
2,316
-8,192
-78% -$173K
CMCM
2297
Cheetah Mobile
CMCM
$87.2M
$52K ﹤0.01%
+2,873
New +$51.4K
FTK icon
2298
Flotek Industries
FTK
$789M
$52K ﹤0.01%
4,318
-5,969
-58% -$68.9K
TTI icon
2299
TETRA Technologies
TTI
$1.08B
$51K ﹤0.01%
25,818
-2,978
-10% -$4.79K
IPI icon
2300
Intrepid Potash
IPI
$476M
$49K ﹤0.01%
1,825
-604
-25% -$16.4K
90 91
92
93 94

Similar funds

OU
Optiver US Chicago, Illinois $50B AUM 53.51% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return

Aperio Group's Q4 2019 Portfolio in Review

As of Q4 2019, Aperio Group held 2,397 positions worth $27.8B, up 10% from $25.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Aperio Group's Q4 2019 filing shows 92 new, 1,264 increased, 960 reduced and 73 closed positions. Its largest new stake was Cerence: 67,887 shares worth $1.54M. The largest sale was Celgene Corp, an estimated $53.1M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q4 2019 buy was Cerence: 67,887 shares worth $1.54M.
  • Aperio Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $37.3M increase.
  • Aperio Group's biggest Q4 2019 reduction was China Mobile Limited, cutting an estimated $16.9M.
  • Aperio Group fully exited Celgene Corp in Q4 2019, selling an estimated $53.1M.
  • Aperio Group's ten largest holdings make up 17% of its $27.8B portfolio in Q4 2019.
  • Aperio Group opened 92 new positions and closed 73 in Q4 2019.
  • Aperio Group's portfolio value rose 10% quarter-over-quarter to $27.8B.

Based on Aperio Group's 13F filing for Q4 2019, filed 13 Feb 2020.